Perioperative management of hereditary arrhythmogenic syndromes

被引:46
|
作者
Staikou, C. [1 ]
Chondrogiannis, K. [1 ]
Mani, A. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Anaesthesia, Aretaieio Hosp, Athens 11528, Greece
关键词
anaesthesia; arrhythmogenic right ventricular dysplasia; Brugada syndrome; channelopathies; congenital long QT syndrome; congenital sick sinus syndrome; polymorphic catecholaminergic ventricular tachycardia; LONG-QT-SYNDROME; SICK SINUS SYNDROME; POLYMORPHIC VENTRICULAR-TACHYCARDIA; BRUGADA-SYNDROME; GENERAL-ANESTHESIA; SPINAL-ANESTHESIA; CESAREAN-SECTION; VOLATILE ANESTHETICS; CARDIAC DYSRHYTHMIAS; SYNDROME MANIFEST;
D O I
10.1093/bja/aes105
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Patients with inherited cardiac channel disorders are at high risk of perioperative lethal arrhythmias. Preoperative control of symptoms and a multidisciplinary approach are required for a well-planned management. Good haemodynamic monitoring, adequate anaesthesia and analgesia, perioperative maintenance of normocarbia, normothermia, and normovolaemia are important. In congenital long QT syndrome, torsades de pointes should be prevented with magnesium sulphate infusion and avoidance of drugs such as droperidol, succinylcholine, ketamine, and ondansetron. Propofol and epidural anaesthesia represent safe choices, while caution is needed with volatile agents. In Brugada syndrome, -blockers, -agonists, and cholinergic drugs should be avoided, while isoproterenol reverses the ECG changes. Propofol, thiopental, and volatiles have been used uneventfully. In congenital sick sinus syndrome, severe bradycardia resistant to atropine may require isoproterenol or epinephrine. Anaesthetics with vagolytic properties are preferable, while propofol and vecuronium should be given with caution due to risk of inducing bradyarrhythmias. Neuraxial anaesthesia should produce the least autonomic imbalance. Arrhythmogenic right ventricular dysplasia/cardiomyopathy induces ventricular tachyarrhythmias, which should be treated with -blockers. Generally, -adrenergic stimulation and catecholamine release should be avoided. Halothane and pancuronium are contraindicated, while large doses of local anaesthetics and epinephrine should be avoided in neuraxial blocks. In catecholaminergic polymorphic ventricular tachycardia, -blocker treatment should be continued perioperatively. Catecholamine release and -agonists, such as isoproterenol, should be avoided. Propofol and remifentanil are probably safe, while halothane and pancuronium are contraindicated. Regional anaesthesia, without epinephrine, is relatively safe. In suspicious cardiac deaths, postmortem examination and familial screening are recommended.
引用
收藏
页码:730 / 744
页数:15
相关论文
共 50 条
  • [1] Syncope in Hereditary Arrhythmogenic Syndromes
    Adler, Arnon
    Viskin, Sami
    CARDIOLOGY CLINICS, 2015, 33 (03) : 433 - +
  • [2] Perioperative management of patients with arrhythmogenic syndromes refractory to medical treatment: A clinical case report
    Rodriguez Alcala, C.
    Maestro Borbolla, A.
    Rodriguez Perez, E.
    Sanabria Carretero, P.
    Reinoso Barbero, F.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2021, 68 (06): : 353 - 356
  • [3] GENETIC ASPECTS OF HEREDITARY ARRHYTHMOGENIC SYNDROMES IN CHILDREN AND ADULTS
    Miranovic, Vesna
    Crnogorac, Snezana
    ACTA CLINICA CROATICA, 2017, 56 (04) : 749 - 755
  • [4] PERIOPERATIVE MANAGEMENT OF PARANEOPLASTIC SYNDROMES
    RUSLANDER, D
    PAGE, R
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1995, 25 (01) : 47 - 62
  • [5] Perioperative management for patients with hereditary angioedema
    Williams, Anesu H.
    Craig, Timothy J.
    ALLERGY & RHINOLOGY, 2015, 6 (01) : E50 - E55
  • [6] Perioperative management of oxygenation in hereditary methaemoglobinaemia
    Limper, Ulrich
    Covrig, Dragos
    Lange, Jonas
    Annecke, Thorsten
    BRITISH JOURNAL OF ANAESTHESIA, 2024, 132 (04) : 793 - 795
  • [7] Management of Colorectal Cancer in Hereditary Syndromes
    Cunningham, Lisa A.
    Gasior, Alessandra
    Kalady, Matthew F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 31 (02) : 307 - 319
  • [8] Clinical Management of Hereditary Breast Cancer Syndromes
    Amy S. Clark
    Susan M. Domchek
    Journal of Mammary Gland Biology and Neoplasia, 2011, 16 : 17 - 25
  • [9] Recognition and management of hereditary colorectal cancer syndromes
    Herraiz, M.
    Munoz-Navas, M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (02) : 125 - 132
  • [10] Hereditary colorectal cancer syndromes: management and surveillance
    Aretz, S.
    Steinke-Lange, V
    Raedle, J.
    GASTROENTEROLOGE, 2020, 15 (04): : 259 - 272